Advertisement

GI & Endoscopy

Xlumena, a privately held provider of innovative technology for gastroenterologists and interventional endoscopists, has received clearance from the US Food and Drug Administration to market its NAVIX Access Device, an advanced endoscopy system designed to enable secure access, dilation and…

A study funded by the National Institute of Diabetes and Digestive and Kidney Diseases found that a significant proportion of irritable bowel syndrome patients treated with cognitive behavior therapy, those called "rapid responders," saw and maintained improvement of their IBS…

Advertisement

Researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively…

Mentor, Ohio-based US Endoscopy is planning a $4.7 million expansion, so the company can continue to design, make and sell its gastrointestinal endoscopy products, with the goal of moving into other specialties, according to a report in MedCity News.

Advertisement